[Does drug therapy increase the dangers of bilirubin encephalopathy during the newborn period?].
D000667:Ampicillin / Q000633:toxicity; D001663:Bilirubin / Q000097:blood; D001769:Blood; D002228:Carbenicillin / Q000633:toxicity; D002512:Cephalothin / Q000633:toxicity; D002675:Child, Preschool; D003091:Colistin / Q000633:toxicity; D003975:Diazepam / Q000633:toxicity*; D004917:Erythromycin / Q000633:toxicity; D005839:Gentamicins / Q000633:toxicity; D006801:Humans; D006863:Hydrogen-Ion Concentration; D006932:Hyperbilirubinemia / Q000139:chemically induced; D007223:Infant; D007231:Infant, Newborn; D007234:Infant, Premature; D007647:Kernicterus / Q000139:chemically induced*; D010068:Oxacillin / Q000633:toxicity; D010634:Phenobarbital / Q000633:toxicity
D005839:Gentamicins; D004917:Erythromycin; D000667:Ampicillin; D002228:Carbenicillin; D003975:Diazepam; D002512:Cephalothin; D001663:Bilirubin; D010068:Oxacillin; D010634:Phenobarbital; D003091:Colistin
Besteht erhöhte Gefahr einer Bilirubinenzephalopathie im Neugeborenenalter durch eine medikamentöse Therapie.